<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0409234099
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1997
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ZYRTEC 0.1% ORAL SOLN.
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CETIRIZINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Oral solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        75
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Aesica Pharmaceuticals S.r.l." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Aesica Pharmaceuticals S.r.l.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Glaxo Saudi Arabia Ltd
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R06AE07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Zyrtec contains active ingredient: cetirizine.dihydrochloride . Cetirizine belongs to a group of anti-allergic medicines called antihistamines.</p><p>Zyrtec is used to treat symptoms associated with allergic conditions, such as:</p><ul><li>nasal and ocular symptoms of seasonal and perennial allergic rhinitis,</li><li>itchy rashes.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Zyrtec:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic (hypersensitive) to cetirizine, hydroxyzine, any piperazine derivatives (closely related active ingredients of other medicines), or to any other ingredients of Zyrtec (listed in Section 6)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have severe kidney disease (severe impairment of kidney function with creatinine clearance below 10ml/min)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you use other antiallergic medicines</p><p>&nbsp;If you think any of these apply to you, <strong>don&rsquo;t</strong> <strong>take</strong> Zyrtec until you have checked with your doctor.</p><p>Take special care with Zyrtec<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_2d18398b-82e7-47e1-a4d7-fd5680b0b96a \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-end'></span></span><![endif]--></p><p><strong>Talk to your doctor or pharmacist</strong> before using Zyrtec:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are a patient with renal insufficiency, please ask your doctor for advice; if necessary, you will take a lower dose. The new dose will be determined by your doctor.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>kidney problems</strong> (your doctor may lower your dose of Zyrtec)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>difficulty passing urine</strong> or you have conditions that make you more likely to be unable to empty your bladder, such as <strong>spinal cord injury</strong> or <strong>enlarged prostate</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>epilepsy </strong>or you are at risk of convulsions (fits)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are pregnant of breast-feeding <em>(see Pregnancy and breast-feeding later in Section 2)</em></p><p>&nbsp;<strong>Check with your doctor </strong>if you think any of these may apply to you<strong>. </strong></p><p><strong>Zyrtec oral solution is not recommended for infants and children under 6 years.</strong></p><p><strong>While you are taking </strong><strong>Zyrtec</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Avoid alcohol while you are taking Zyrtec.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Zyrtec may affect your <strong>allergy test</strong> results. If you are scheduled for allergy testing, ask your doctor if you should stop taking Zyrtec for several days before testing.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contact your doctor if you have high temperature (fever), shivering or chills, as you may require other type of treatment.</p><p><strong>Conditions you need to look out for</strong></p><p>Zyrtec can make some existing conditions worse, or cause <strong>severe allergic reactions or urinary retention. </strong>Some people may have suicidal thoughts when taking Zyrtec. You must look out for certain symptoms while you are taking Zyrtec, to reduce the risk of any problems. See &lsquo;Conditions you need to look out for&rsquo;<em> </em>in Section 4.</p><p>Other medicines and Zyrtec<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_93f15f9d-27d8-43b4-92bd-0dcd8bf9b6e1 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-end'></span></span><![endif]--></p><p><strong>Tell your doctor or pharmacist if you&#39;re taking any other medicines</strong>, if you&rsquo;ve taken any recently, or if you start taking new ones. This includes medicines bought without a prescription.</p><p>Some medicines may affect how Zyrtec works, or make it more likely that you&rsquo;ll have side effects. Zyrtec can also affect how some other medicines work. These include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines acting on the brain, for example<strong> other </strong><strong>antihistamines </strong>such as hydroxizine, clemastine, <strong>medicines used to treat anxiety</strong> such as diazepam or <strong>sleeping pills</strong> such as zolpidem (concurrent administration of Zyrtec with other agents acting on the brain may cause additional reductions in alertness and impairment of performance, <em>see &lsquo;Food and drink with <strong>Zyrtec</strong>&rsquo; later in Section 2</em>).</p><p>&nbsp; &nbsp;<strong>Tell your doctor or pharmacist </strong>if you are taking any of these.</p><p><strong>Food and drink with Zyrtec</strong></p><p>Avoid alcohol when you are taking Zyrtec. In sensitive patients, the concurrent administration of Zyrtec and alcohol may cause additional reductions in alertness and impairment of performance.</p><p><strong>Pregnancy and breast-feeding</strong></p><p><strong>Zyrtec</strong><strong> </strong><strong>should be avoided in pregnant women.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Tell your doctor if you are pregnant</strong> or planning to become pregnant.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you do become pregnant during treatment</strong> with Zyrtec, tell your doctor.</p><p>The ingredients in Zyrtec can pass into breast milk. <strong>If you are breast-feeding, you must check with your doctor</strong> before you take Zyrtec.</p><p><strong>Driving and using machines</strong></p><p>Zyrtec at the recommended dose is unlikely to affect your ability to drive or use machines. However, some patients being treated with <strong>Zyrtec may feel drowsy, tired or weak</strong> (see &lsquo;Possible side effects&rsquo; in Section 4).</p><p>&nbsp;<strong>&nbsp;Don&rsquo;t drive or use machines</strong> unless you are sure you&rsquo;re not affected.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>How much to take<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_cc33152d-46ad-48d0-93ec-beeac9eead1f \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-end'></span></span><![endif]--></p><p><strong>Always take Zyrtec exactly as</strong> <strong>described in this leaflet or as your</strong> <strong>doctor or pharmacist have told you.</strong> Check with your doctor or pharmacist if you are not sure.</p><p><strong>Don&rsquo;t take </strong>more than the recommended dose</p><p><strong>Don&rsquo;t take Zyrtec </strong>for longer than <strong>7 days</strong>, without advice of your doctor or pharmacist.</p><p>&nbsp;<strong>C</strong><strong>ontact your doctor</strong> if your symptoms worsen or do not improve after 3 days.</p><p><strong><u>Adults and adolescents above 12 years old</u></strong></p><p>The usual dose of Zyrtec oral solution, is 10 mL (10 mg), once a day.</p><p><strong><u>Children between 6 and 12 years old</u></strong></p><p>The usual dose<strong> </strong>of Zyrtec oral solution, is 5 mg as 5 mL (one full measuring spoon), twice a day.</p><p><strong><u>Children between 2 and 6 years old</u></strong></p><p>The usual dose<strong> </strong>of Zyrtec oral solution, is 2.5 mL (2.5mg), twice a day.</p><p><strong>Patients with kidney and liver disease:</strong></p><p>Your doctor will decide on the correct dose of&nbsp;Zyrtec depending on the illness and the results of blood tests carried out before treatment. Patients who have end stage impairment of kidney function must not take&nbsp;Zyrtec&nbsp;(see &lsquo;Don&rsquo;t take&nbsp;Zyrtec&rsquo;, in section 2).</p><p>If your child suffers from kidney disease, please contact your doctor or pharmacist who may adjust the dose accordingly.</p><p><strong>How to take Zyrtec&nbsp;&nbsp; </strong></p><p>The Zyrtec solution can be swallowed as such.</p><p>If you forget to take Zyrtec<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_d81c9c54-7e0d-4d22-ad40-2fa151657c0b \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-end'></span></span><![endif]--></p><p><strong>Don&#39;t take an extra dose to make up for a missed dose</strong>. Just take your next dose at the usual time.</p><p>&nbsp;<strong>If you are not sure what to do</strong>, ask your doctor or pharmacist.</p><p>If you take too much Zyrtec<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_e85eaea0-8376-4936-a291-9c4614fab5e5 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-end'></span></span><![endif]--></p><p>If you take too much Zyrtec, <strong>contact your doctor or pharmacist for advice.</strong> If possible, show them the Zyrtec pack.</p><p>If you take too much Zyrtec you may be <strong>more likely to have side effects such as:</strong> confusion, diarrhoea, dizziness, tiredness, headache, malaise, dilating of pupil, itching, restlessness, sedation, somnolence (feeling drowsy), stupor, abnormal rapid heart rate, tremor, urinary retention.</p><p>If you stop taking Zyrtec<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_36aa1c0b-0abc-458a-a89b-8d7b28cf834a \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:windowtext'><span style='mso-element:field-end'></span></span><![endif]--></p><p>Rarely, pruritus (intense itching) and/or urticaria may occur if you stop taking Zyrtec.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Zyrtec can cause side effects, but not everybody gets them</p><p><strong>Conditions you need to look out for:</strong></p><p><strong>Severe allergic reactions.</strong> Signs include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; raised and itchy rash (<em>hives</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling, sometimes of the face or mouth (<em>angioedema</em>), causing difficulty in swallowing or breathing</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; collapse or loss of consciousness</p><p><strong>Urinary retention. </strong>Signs include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain when passing urine or inability to pass urine</p><p><strong>Suicidal thoughts.</strong> Some people had suicidal thoughts when taking Zyrtec.</p><p>&nbsp;<strong>Contact a doctor immediately </strong>if you get these symptoms.<strong> Stop taking Zyrtec.</strong></p><p>Common side effects<!--[if supportFields]><span lang=EN-GB style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-fareast-font-family:
"MS Mincho";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:black;mso-themecolor:text1;mso-fareast-language:JA'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_9315b242-a15f-4298-9ed2-35d7fc85b1d5 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-fareast-font-family:"MS Mincho";mso-hansi-theme-font:major-bidi;
mso-bidi-theme-font:major-bidi;color:black;mso-themecolor:text1;mso-fareast-language:
JA'><span style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>up to 1 in 10 </strong>people:</p><ul><li>Somnolence (sleepiness)</li><li>Dizziness, headache</li><li>Pharyngitis, rhinitis (in children)</li><li>Diarrhoea (in children), nausea, dry mouth</li><li>Fatigue</li></ul><p>Uncommon side effects<!--[if supportFields]><span lang=EN-GB style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-fareast-font-family:
"MS Mincho";mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
color:black;mso-themecolor:text1;mso-fareast-language:JA'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_6657da5e-90c2-4465-9cc2-843fdcaa67d2 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-fareast-font-family:"MS Mincho";mso-hansi-theme-font:major-bidi;
mso-bidi-theme-font:major-bidi;color:black;mso-themecolor:text1;mso-fareast-language:
JA'><span style='mso-element:field-end'></span></span><![endif]--></p><p>These may affect <strong>up to 1 in 100</strong> people:</p><ul><li>Agitation</li><li>Paraesthesia (tingling or numbness of the hands or feet)</li><li>Diarrhoea</li><li>Stomach pain</li><li>Pruritus (itching), rash</li><li>Asthenia (unusual weakness), malaise</li></ul><p><strong>Rare side effects</strong></p><p>These may affect <strong>up to 1 in 1,000</strong> people:</p><ul><li>Hypersensitivity</li><li>Aggression, confusion, depression, hallucination, insomnia (sleeplessness)</li><li>Convulsions</li><li>Tachycardia (fast heart beat)</li><li>Liver function abnormal (reflected in the blood tests)</li><li>Urticaria</li><li>Oedema (swelling)</li><li>Increased weight</li></ul><p><strong>Very rare side effects</strong></p><p>These may affect <strong>up to 1 in 10,000</strong> people:</p><ul><li>Thrombocytopenia (low blood platelets count)</li><li>Anaphylactic shock (see &lsquo;Severe allergic reactions&rsquo; earlier in section 4)</li><li>Tics (uncontrolled body movement)</li><li>Dysgeusia (taste disturbance or loss of taste), dyskinesia (uncontrollable movements), dystonia (uncontrolled muscle spasm), syncope (fainting), tremor</li><li>Accommodation disorder (difficulty focusing), blurred vision, oculogyration (eyes having uncontrolled circular movements)</li><li>Angioedema (serious allergic reaction which causes swelling of the face or throat), fixed drug eruption</li><li>Dysuria (pain when passing urine) (see &lsquo;Urinary retention&rsquo; earlier in section 4), enuresis (bed wetting)</li></ul><p><strong>Other side effects</strong></p><p>Have occurred but their exact frequency is unknown:</p><ul><li>Increased appetite</li><li>Suicidal ideation (see &lsquo;Suicidal thoughts&rsquo; earlier in section 4), nightmare</li><li>Amnesia, memory impairment</li><li>Vertigo (spinning sensation)</li><li>Inflammation of the liver</li><li>Urinary retention (difficulty passing urine) (see &lsquo;Urinary retention&rsquo; earlier in section 4)</li><li>Joint Pain</li><li>Rash with blisters containing pus</li><li>Intense itching (pruritis) upon discontinuation<br />&nbsp;</li></ul><p>&nbsp;&nbsp;<strong>Tell your doctor or pharmacist</strong> if any of the side effects listed becomes severe or troublesome, or if you notice side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Keep out of the reach and sight of children.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use Zyrtec after the expiry date which is stated on the pack after &lsquo;Exp&rsquo;.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store Zyrtec below 30&deg;C in dry place.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After-first opening, bottle should be stored at room temperature and to be used within 3 months.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your doctor tells you to stop taking Zyrtec, it is important to return any remnants which are left over to your pharmacist.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p><p><!--[if !supportLists]--></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Zyrtec contains</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Active ingredients:</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each 1ml contains 1mg cetirizine dihydrochloride.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other non-active ingredients:</p><p>Sorbitol solution at 70 % (non-crystallizing)</p><p>Glycerol 85%</p><p>Propylene glycol</p><p>Saccharin sodium</p><p>Methyl parahydroxybenzoate</p><p>Propyl parahydroxybenzoate</p><p>Banana flavor 54.330/A</p><p>Sodium acetate</p><p>Glacial acetic acid</p><p>Purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Zyrtec Oral Solution looks like and contents of the pack
Clear and colourless liquid with slightly sweet taste and a banana flavour.
Amber glass bottle (type III Ph. Eur.) closed with a white polypropylene “child-proof” cap.
Bottle of 75 ml.
Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Trademarks are owned by or licensed to the GSK group of companies</p><p>&copy; 2023 GlaxoSmithKline, all rights reserved.</p><p><strong>Manufactuered by:</strong></p><p>Aesica Pharmaceuticals S.R.l., Pianezza, Italy</p><p><strong>Marketing Authorization Holder</strong></p><p>Glaxo Saudi Arabia Ltd.*, Jeddah, KSA</p><p>*member of the GlaxoSmithKline group of companies</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK- Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com</li><li>Website: https://gskpro.com/en-sa/<u> </u></li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul><p><strong>To report any side effect(s):</strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting Hotline : 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p><strong>-GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: saudi.safety@gsk.com</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O Box 55850, Jeddah 21544, Saudi Arabia</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version number: 08 
Version date: 11 April 2023 



            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي زيرتيك على دواء يدعى سيتيريزين دايهيدروكلوريد. ينتمي السيتريزين إلى مجموعة من الأدوية المضادة للحساسية تسمى مضادات الهيستامين.</p><p dir="RTL">يستخدم زيرتيك لعلاج الأعراض المرتبطة بأمراض الحساسية، مثل:</p><p dir="RTL">&bull; الأنف والعين أعراض التهاب الأنف التحسسي الموسمية أو المستمره طوال العام.</p><p dir="RTL">&bull; حكة الطفح الجلدي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا يجوز تناول زيرتيك</strong>:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا كنت تعاني من حساسية (فرط الحساسية) من السيتريزين، هيدروكسيزين، أي مشتقات بيبيرازين (المكونات الفعالة المشابهه من الأدوية الأخرى)، أو إلى أي مكونات أخرى من زيرتيك (المدرجة في القسم 6)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا كان لديك مرض الكلى الحاد (ضعف شديد في وظائف الكلى مع تصفية الكرياتينين أقل من 10مل / دقيقة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا كنت تستخدم أدوية مضادة للحساسية أخرى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا كنت تعتقد أن أي من هذه الحالات ينطبق عليك، فلا تأخذ زيرتيك حتى يقوم الطبيب بفحصك.</p><p dir="RTL"><strong>يجب توخي الحذر عند استعمال زيرتيك:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تحدث مع طبيبك أو الصيدلي قبل استخدام زيرتيك:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مريضا تعاني من قصور كلوي، من فضلك اطلب من الطبيب الحصول على المشورة، إذا لزم الأمر، وسوف تأخذ جرعة أقل. وسيتم تحديد الجرعة الجديدة من قبل الطبيب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك مشاكل في الكلى (قد يخفض طبيبك جرعة الزيرتيك)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك صعوبة في تمرير البول أو لديك ظروف تجعلك أكثر عرضة لعدم القدرة على إفراغ المثانة، مثل إصابة الحبل الشوكي أو البروستاتا الموسع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك صرع أو كنت في مرحلة خطيرة من التشنجات (نوبة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ حاملاً&nbsp; أو تقومين بالرضاعة الطبيعية (انظري الحمل والرضاعة الطبيعية لاحقا في القسم 2)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يرجى مراجعة طبيبك إذا كنت تعتقد أن أي من هذه الأعراض قد تنطبق عليك.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا ينصح باستخدام أقراص زيرتيك للأطفال الذين دون سن 6 سنوات، هذا الشكل الصيدلاني لا يسمح بالوصول للجرعة المناسبة.</p><p dir="RTL"><strong>وأنت تأخذ زيرتيك</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجنب الكحول أثناء تناول زيرتيك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يؤثر زيرتيك على نتائج <strong>اختبارات الحساسية</strong>. إذا كانت لديك اختبارات حساسية مجدولة، اسأل طبيبك إذا كان يجب عليك التوقف عن أخذ زيرتيك لعدة أيام قبل الاختبار.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتصل بطبيبك إذا كان لديك ارتفاع في درجة الحرارة )حمى( أو رجفه أو قشعريرة، حيث قد تحتاج إلى نوع آخر من العلاج.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشروط التي تحتاج إلى البحث عنها</strong></p><p dir="RTL">زيرتيك يمكن أن يجعل بعض الظروف الحالية أسوأ، أو يسبب <strong>حساسية أو احتباس البول</strong>. قد يكون لدى بعض الناس أفكار انتحارية عند أخذ زيرتيك. يجب أن تبحث عن أعراض معينة بينما تأخذ زيرتيك، للحد من مخاطر أي مشاكل. انظر &quot;الشروط التي تحتاج إلى البحث عنها&quot; في القسم 4.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أدوية أخرى و زيرتيك</strong></p><p>يرجى إبلاغ الطبيب أو الصيدلي إذا كنت تتناول أو تناولت مؤخراً أية أدوية أخرى ، إذا كنت قد اتخذت مؤخرا، أو إذا بدأت في أخذ أدوية جديدة. ويشمل ذلك الأدوية التي يتم شراؤها بدون وصفة طبية.</p><p>قد تؤثر بعض الأدوية على كيفية عمل زيرتيك، أو تجعل من الأرجح أن يكون لديك آثار جانبية. زيرتيك يمكن أن يؤثر أيضا على كيفية عمل بعض الأدوية الأخرى. وتشمل هذه:</p><p>&bull; الأدوية التي تعمل على الدماغ، على سبيل المثال مضادات الهيستامين الأخرى مثل هيدروكسيزين، كليماستين، والأدوية المستخدمة لعلاج القلق مثل الديازيبام أو حبوب النوم مثل الزولبيديم (التناول المتزامن لزيرتيك مع العوامل الأخرى التي تعمل على الدماغ قد تسبب زيادة الإنخفاض في اليقظة و ضعف الأداء، انظر &quot;الطعام والشراب مع زيرتيك&quot; لاحقا في القسم 2).</p><p><strong>&not; </strong><strong>أخبر طبيبك أو الصيدلي إذا كنت تتناول أي مما سبق ذكره أعلاه.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الطعام والشراب مع زيرتيك</strong></p><p>تجنب الكحول وأنت تأخذ زيرتيك. في المرضى الحساسين، والتناول المتزامن من زيرتيك والكحول قد يسبب زيادة الإنخفاض في اليقظة وضعف الأداء.</p><p>&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p>&nbsp;يجب تجنب اعطاء زيرتك للنساء الحوامل.</p><p><strong>&bull; أخبري طبيبك إذا كنت حاملا</strong> أو تظنين أنك قد تكونين حامل.</p><p>&bull; إذا أصبحتي حاملا أثناء العلاج بزيرتيك، أخبري طبيبك.</p><p>المكونات في زيرتيك يمكن أن تمر في حليب الثدي. إذا كنت مرضعة، يجب عليك مراجعة الطبيب قبل أن تأخذي زيرتيك.</p><p>&nbsp;</p><p dir="RTL"><strong>التأثيرات على القدرة على قيادة السيارات واستعمال الماكينات</strong></p><p>من غير المرجح أن يؤثر زيرتيك بالجرعة الموصى بها على قدرتك على القيادة أو استخدام الآلات. ومع ذلك، قد يشعر بعض المرضى الذين يتعالجون بزيرتيك بالنعاس، والتعب أو الضعف (انظر &quot;الآثار الجانبية المحتملة&quot; في القسم 4).</p><p>&not; <strong>لا تقود أو تستعمل الآلات</strong> ما لم تكن متأكدا من أنك لن تتأثر</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ماهي الجرعة التي سوف تتناولها</strong></p><p dir="RTL"><strong>تناول زيرتيك دائما بالضبط كما هو موضح في هذه النشرة أو كما قال لك</strong> <strong>الطبيب أو الصيدلي.</strong> تحقق مع طبيبك أو الصيدلي إذا كنت غير متأكد.</p><p dir="RTL"><strong>لا تأخذ</strong> أكثر من الجرعة الموصى بها</p><p dir="RTL"><strong>لا تأخذ زيرتيك</strong> لمدة أطول من <strong>7 أيام</strong>، دون استشارة الطبيب أو الصيدلي.</p><p dir="RTL">&not; <strong>اتصل</strong><strong> </strong><strong>بطبيبك</strong> إذا تضاعفت الأعراض أو لم تتحسن بعد 3 أيام.</p><p dir="RTL"><strong><u>البالغين والمراهقين فوق 12 سنة</u></strong></p><p dir="RTL">الجرعة المعتادة من زيرتيك هي 10 مل (10 ملجم) محلول للإعطاء عن طريق الفم ، مرة واحدة في اليوم.</p><p dir="RTL"><strong><u>الأطفال الذين تتراوح أعمارهم بين 6 و 12 سنة</u></strong></p><p dir="RTL">الجرعة المعتادة من زيرتيك هي 5 ملجم أي 5 مل (ملعقة قياس كاملة) محلول للإعطاء عن طريق الفم ، مرتين في اليوم.</p><p dir="RTL"><strong><u>الأطفال بين 2 و 6 سنوات من العمر</u></strong></p><p dir="RTL">الجرعة المعتادة من زيرتيك هي 2.5 مل (2.5ملجم) محلول للإعطاء عن طريق الفم ، مرتين في اليوم.</p><p dir="RTL"><strong>المرضى الذين يعانون من أمراض الكلى والكبد:</strong></p><p dir="RTL">سوف يقرر طبيبك الجرعة الصحيحة من زيرتيك اعتمادا على المرض ونتائج اختبارات الدم التي أجريت قبل العلاج. المرضى الذين لديهم نهاية المرحلة ضعف وظائف الكلى يجب ألا تأخذ زيرتيك (انظر &#39;لا تأخذ زيرتيك&#39;، في القسم 2).</p><p dir="RTL">إذا كان طفلك يعاني من أمراض الكلى، يرجى الاتصال بطبيبك أو الصيدلي الذي قد يعدل الجرعة وفقا لذلك.</p><p dir="RTL"><strong>كيفية التناول </strong></p><p dir="RTL">يمكن ابتلاع محلول زيرتيك كما هو دون الحاجة الى تخفيفه.</p><p dir="RTL"><strong>إذا نسيت تناول زيرتيك</strong></p><p dir="RTL"><strong>لا تتناول جرعة إضافية لتعويض الجرعة المفقودة. </strong>فقط تناول الجرعة التالية في الوقت المعتاد.</p><p dir="RTL">&not; <strong>إذا</strong><strong> </strong><strong>لم</strong><strong> </strong><strong>تكن</strong><strong> </strong><strong>متأكدا</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>يجب</strong><strong> </strong><strong>فعله،</strong> اسأل طبيبك أو الصيدلي.</p><p dir="RTL"><strong>إذا تناولت أكثر مما يجب تناوله من زيرتيك</strong></p><p dir="RTL">إذا تناولت الكثير من زيرتيك، اتصل بطبيبك أو الصيدلي للحصول على الاستشارة. إذا كان ذلك ممكنا، أحضر عبوة الزيرتيك..</p><p dir="RTL">إذا كنت تأخذ الكثير من زيرتيك قد يكون <strong>من المرجح أن يكون لها آثار جانبية مثل:</strong> الارتباك والإسهال والدوار والتعب والصداع والشعور بالضيق، وتمدد الحدقة، والحكة، والأرق، والتخدير، والنعاس (الشعور بالنعاس)، ذهول، وسرعة غير طبيعية ومعدل ضربات القلب، ورعاش، واحتباس البول.</p><p dir="RTL"><strong>إذا توقفت عن تناول زيرتيك</strong></p><p dir="RTL">نادرا ما تحدث الحكة (الحكة الشديدة) و / أو الشرى إذا توقفت عن تناول زيرتيك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كشأن كافة الأدوية، زيرتيك قد يسبب آثاراً جانبية، إلا أنها لا تصيب كل فرد.</p><p dir="RTL">الأعراض التي يجب الانتباه لها:</p><p dir="RTL"><strong>ردود فعل تحسسية شديدة.</strong> وتشمل العلامات:</p><p dir="RTL">&bull; طفح جلدي (حكة)</p><p dir="RTL">&bull; تورم، وأحيانا من الوجه أو الفم (الوذمة الوعائية)، مما تسبب في صعوبة في البلع أو التنفس</p><p dir="RTL">&bull; انهيار أو فقدان الوعي</p><p dir="RTL"><strong>احتباس البول.</strong> وتشمل العلامات:</p><p dir="RTL">&bull; ألم عند تمرير البول أو عدم القدرة على تمرير البول</p><p dir="RTL"><strong>أفكار انتحارية</strong>. بعض الناس كان لديهم أفكار انتحارية عندما تناولوا زيرتيك.</p><p dir="RTL"><strong>&not; </strong><strong>اتصل</strong><strong> </strong><strong>بالطبيب</strong><strong> </strong><strong>فورا</strong><strong> </strong>إذا حصلت على هذه الأعراض. <strong>توقف</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>أخذ</strong><strong> </strong><strong>زيرتيك</strong><strong>.</strong></p><p dir="RTL"><strong>آثار جانبية الشائعة</strong><strong> </strong></p><p dir="RTL"><strong>(تصيب أقل من فرد واحد من كل 10 أفراد)</strong></p><p dir="RTL">&bull; نعاس (النعاس)</p><p dir="RTL">&bull; الدوخة والصداع</p><p dir="RTL">&bull; التهاب البلعوم، التهاب الأنف (في الأطفال)</p><p dir="RTL">&bull; الإسهال (في الأطفال)، والغثيان، وجفاف الفم</p><p dir="RTL">&bull; إعياء</p><p dir="RTL"><strong>آثار جانبية غير شائعة</strong></p><p dir="RTL"><strong>&nbsp;(تصيب أقل من فرد واحد من كل 100 فرد)</strong></p><p dir="RTL">&bull; التحريض</p><p dir="RTL">&bull; تخدير (وخز أو خدر في اليدين أو القدمين)</p><p dir="RTL">&bull; إسهال</p><p dir="RTL">&bull; آلام في المعدة</p><p dir="RTL">&bull; هرش (حكة)، طفح جلدي</p><p dir="RTL">&bull; الوهن (ضعف غير عادي)، والشعور بالضيق</p><p dir="RTL"><strong>آثار جانبية نادرة</strong></p><p dir="RTL"><strong>(تصيب أقل من فرد واحد من كل 1000 فرد)</strong></p><p dir="RTL">&bull; فرط الحساسية</p><p dir="RTL">&bull; عدوانية، ارتباك، اكتئاب، هلوسة، أرق (صعوبة في النوم)</p><p dir="RTL">&bull; التشنجات</p><p dir="RTL">&bull; عدم انتظام دقات القلب (ضربات القلب السريعة)</p><p dir="RTL">&bull; وظيفة الكبد الغير طبيعية (تنعكس في اختبارات الدم)</p><p dir="RTL">&bull; الشرى</p><p dir="RTL">&bull; وذمة (تورم)</p><p dir="RTL">&bull; زيادة في الوزن</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية نادرة جدا</strong></p><p dir="RTL"><strong>(تصيب أقل من فرد واحد من كل 10000 فرد)</strong></p><p dir="RTL">&bull; نقص الصفائح (انخفاض عدد الصفائح الدموية)</p><p dir="RTL">&bull; صدمة تحسسية (انظر &quot;ردود الفعل التحسسية الشديدة&quot; في القسم 4)</p><p dir="RTL">&bull; تشنجات لاإرادية (حركة الجسم غير المنضبط)</p><p dir="RTL">&bull; فقد المذاق (اضطرابات بالتذوق أو فقدان التذوق)، خلل الحركة (حركات لا يمكن السيطرة عليها)، خلل التوتر (تشنج العضلات غير المنضبط)، إغماء (الوهن)، رعاش</p><p dir="RTL">&bull; اضطراب التأقلم (صعوبة التركيز)، عدم وضوح الرؤية، دوران في العين (وجود حركات دائرية غير منضبطة في العيون)</p><p dir="RTL">&bull; وذمة وعائية (رد فعل تحسسي خطير يسبب تورم في الوجه أو الحلق)، طفح دوائي ثابت</p><p dir="RTL">&bull; عسر البول (الألم عند تمرير البول) (انظر &quot;احتباس البول&quot; في القسم 4)، سلس البول (التبول في الفراش)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية الأخرى</strong></p><p dir="RTL">حدثت ولكن تكرارها بالضبط غير معروف:</p><p dir="RTL">&bull; زيادة الشهية</p><p dir="RTL">&bull; التفكير الانتحاري (انظر &quot;الأفكار الانتحارية&quot; في وقت سابق في القسم 4)، كوابيس</p><p dir="RTL">&bull; فقدان الذاكرة، ضعف الذاكرة</p><p dir="RTL">&bull; الدوار (الإحساس بالدوار)</p><p dir="RTL">&bull; التهاب الكبد</p><p dir="RTL">&bull; احتباس البول (صعوبة تمرير البول) (انظر &quot;الاحتفاظ البولي&quot; في القسم 4)</p><p dir="RTL">&bull; ألم في المفاصل<br />&bull; طفح جلدي مع ظهور دمامل يتجمع فيها القيح<br />&bull; حكة شديدة عند التوقف</p><p dir="RTL">&nbsp;</p><p dir="RTL">&not; <strong>أخبر</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong> إذا كان أي من الآثار الجانبية المدرجة أصبحت شديده أو مزعجه، أو إذا لاحظت آثار جانبية غير مدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>يحفظ بعيداً عن متناول ونظر الأطفال.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيرتيك لا يجوز استعماله بعد تاريخ انتهاء الصلاحية المبين على العبوة بعد كلمة &quot;Exp&quot;.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب حفظ زيرتيك بدرجة حرارة أقل من 30&deg; م في مكان جاف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعد فتح القارورة يجب تخزينها في درجة حرارة الغرفة ويجب أن تستعمل خلال 3 أشهر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أخبرك الطبيب بوقف تناول زيرتيك، فمن المهم إعادة أي كمية متبقية إلى الصيدلي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يجوز التخلص من الأدوية في مياه الصرف الصحي أو المخلفات المنـزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه التدابير تساعد على وقاية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الفعالة:</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كل 1مل يحتوي على 1 ملجم سيتيريزين دايهيدروكلوريد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مكونات أخرى غير فعالة:</p><p dir="RTL">&nbsp;محلول سوربيتول تركيزه 70٪ (غير مبلور)</p><p dir="RTL">جليسرول &nbsp;85%</p><p dir="RTL">پروپـيلين جلايكول.</p><p dir="RTL">سكارينات الصوديوم.</p><p dir="RTL">ميثيل پارا هيدروكسي بـنـزوات</p><p dir="RTL">پروپيل پارا هيدروكسي بـنـزوات</p><p dir="RTL">نكهة الموز 54.330/A</p><p dir="RTL">أسيتات الصوديوم</p><p dir="RTL">حمض الأسيتيك الثلجي</p><p dir="RTL">ماء منقي</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سائل شفاف عديم اللون بطعم سكري خفيف ونكهة الموز.</p><p dir="RTL">زجاجة مصنوعة من زجاج كهرماني (من النوع III وفقاً لدستور الأدوية الأوروبي) مغلقة بغطاء أبيض &quot;مقاوم لعبث الأطفال&quot; مصنوع من الپولي پروپـيلين.</p><p dir="RTL">زجاجة تحتوي على 75 مل.</p><p dir="RTL">قد لا تسوّق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">العلامات التجارية مملوكة إلى أو مرخصة لصالح مجموعة شركات جلاكسو سميث كلاين.</p><p dir="RTL">&copy; 2023 جلاكسو سميث كلاين، جميع الحقوق محفوظة.</p><p dir="RTL"><strong>تصنيع</strong></p><p dir="RTL">ايسكا فارماسيوتيكالز إس أر آي، پيانزا، إيطاليا</p><p dir="RTL"><strong>صاحبة رخصة التسويق</strong></p><p dir="RTL">جلاكسو العربية السعودية المحدودة *، جده، المملكة العربية السعودية</p><p dir="RTL">* شركة تنتمي إلى مجموعة شركات جلاكسو سميث كلاين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للاستفسار عن أية معلومات عن هذا المستحضر الدوائي، يرجى الاتصال بالأرقام التالية:</strong></p><p dir="RTL">جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</p><p dir="RTL">هاتف: 6536666 -12- 966+</p><p dir="RTL">جوال: 9882-904-56-966+</p><p dir="RTL">البريد الإلكتروني gcc.medinfo@gsk.com :</p><p dir="RTL">الموقع الإلكتروني: <u>https://gskpro.com/en-sa/</u></p><p dir="RTL">ص.ب 55850، جدة 21544، المملكة العربية السعودية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            إصدار رقم: 08
تاريخ الإصدار: 11 أبريل 2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cetirizine dihydrochloride, 1 mg/ml, oral solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 1 ml contains 1 mg of cetirizine dihydrochloride.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Clear and colourless liquid with a slightly sweet taste and a banana flavour.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For the relief of:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nasal and ocular symptoms of seasonal and perennial allergic rhinitis,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; symptoms of urticaria.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The solution can be swallowed as such.</p><p>Route of Administration<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_d9f69003-a654-4d02-b27c-b198dbfc952b \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>For oral use.</p><p>Adults<!--[if supportFields]><span lang=EN-GB
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_66fc34c9-42c0-42a9-8d06-4f2fbe04d7fc \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>10 mg (20 drops or 10 ml of oral solution or 1 tablet or 1 capsule) once daily.</p><p>A 5 mg starting dose (10 drops or 5 ml of oral solution or half of the tablet) may be proposed if this leads to satisfactory control of the symptoms.</p><p>Children<!--[if supportFields]><span lang=EN-GB
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_cf32e0f5-5c92-4655-8ca1-33efc79844c9 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p><strong><em>Children aged from 2 to 6 years</em></strong></p><p>2.5 mg (5 drops or 2.5 ml of oral solution) twice daily.</p><p><strong><em>Children aged from 6 to 12 years</em></strong></p><p>5 mg (10 drops or 5 ml of oral solution or half of the tablet) twice daily.</p><p><strong><em>Children over 12 years of age </em></strong></p><p>10 mg (20 drops or 10 ml of oral solution or 1 tablet or 1 capsule) once daily.</p><p>Elderly<!--[if supportFields]><span lang=EN-GB
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_12a80428-5f7f-4e93-9b09-c4b8e7e51b90 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Data does not suggest that the dose needs to be reduced in elderly subjects provided that the renal function is normal.</p><p>Renal impairment<!--[if supportFields]><span lang=EN-GB
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_50c426af-c777-42d2-a752-1480a7d157f0 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Since cetirizine is mainly excreted via renal route, in cases no alternative treatment can be used, the dosing intervals must be individualised according to renal function.</p><p>Refer to the following table and adjust the dose as indicated.&nbsp;</p><p><!--[if gte vml 1]><v:rect
 id="Rectangle_x0020_1" o:spid="_x0000_s1027" style='position:absolute;
 margin-left:27.6pt;margin-top:28.75pt;width:57.6pt;height:28.8pt;z-index:251663360;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
 mso-height-relative:page;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" o:allowincell="f" stroked="f"/><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>CL<sub>cr </sub>=</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p><img alt="" src="data:image/png;base64,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" /></p><p><!--[if gte vml 1]><o:wrapblock><v:shapetype id="_x0000_t75"
  coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
  filled="f" stroked="f">
  <v:stroke joinstyle="miter"/>
  <v:formulas>
   <v:f eqn="if lineDrawn pixelLineWidth 0"/>
   <v:f eqn="sum @0 1 0"/>
   <v:f eqn="sum 0 0 @1"/>
   <v:f eqn="prod @2 1 2"/>
   <v:f eqn="prod @3 21600 pixelWidth"/>
   <v:f eqn="prod @3 21600 pixelHeight"/>
   <v:f eqn="sum @0 0 1"/>
   <v:f eqn="prod @6 1 2"/>
   <v:f eqn="prod @7 21600 pixelWidth"/>
   <v:f eqn="sum @8 21600 0"/>
   <v:f eqn="prod @7 21600 pixelHeight"/>
   <v:f eqn="sum @10 21600 0"/>
  </v:formulas>
  <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
  <o:lock v:ext="edit" aspectratio="t"/>
 </v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" style='position:absolute;
  margin-left:85.2pt;margin-top:1.85pt;width:250pt;height:35pt;z-index:251662336'
  o:allowincell="f">
  <v:imagedata src="file:///C:/Users/ml776704/AppData/Local/Temp/msohtmlclip1/01/clip_image001.wmz"
   o:title=""/>
  <w:wrap type="topAndBottom"/>
 </v:shape><![if gte mso 9]><o:OLEObject Type="Embed" ProgID="Equation.3"
  ShapeID="_x0000_s1026" DrawAspect="Content" ObjectID="_1795003267">
 </o:OLEObject>
 <![endif]><![endif]--></p><table cellpadding="0" cellspacing="0" align="left" style="width:334.037px"><tbody><tr><td style="width:1px">&nbsp;</td></tr><tr><td style="width:1px">&nbsp;</td><td style="width:333.963px">&nbsp;</td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>Dosing adjustments for adult patients with impaired renal function</p><table border="1" cellspacing="0" cellpadding="0" style="width:581px"><tbody><tr><td style="vertical-align:top"><p><strong>Group</strong></p></td><td style="vertical-align:top"><p><strong>GFR (ml/min)</strong><strong> (ml/min)</strong></p></td><td style="vertical-align:top"><p><strong>Dosage and frequency</strong></p></td></tr><tr><td style="vertical-align:top"><p>Normal renal function</p></td><td style="vertical-align:top"><p>&sup3;90</p></td><td style="vertical-align:top"><p>10 mg once daily</p></td></tr><tr><td style="vertical-align:top"><p>Mild decrease renal function</p></td><td style="vertical-align:top"><p>60&ndash; &lt; 90</p></td><td style="vertical-align:top"><p>10 mg once daily</p></td></tr><tr><td style="vertical-align:top"><p>Moderately decreased renal function</p></td><td style="vertical-align:top"><p>30 &ndash; &lt; 60</p></td><td style="vertical-align:top"><p>5 mg once daily</p></td></tr><tr><td style="vertical-align:top"><p>Severely decreased renal function</p></td><td style="vertical-align:top"><p>15 - &lt; 30 not requiring dialysis treatment</p></td><td style="vertical-align:top"><p>5 mg once every 2 days</p></td></tr><tr><td style="vertical-align:top"><p>End-stage renal disease -</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&lt;15 requiring dialysis treatment</p></td><td style="vertical-align:top"><p>Contraindicated</p></td></tr></tbody></table><p>In paediatric patients suffering from renal impairment, the dose will have to be adjusted on an individual basis taking into account the renal clearance, age and body weight of the patient.</p><p>Hepatic impairment<!--[if supportFields]><span lang=EN-GB style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
major-bidi;mso-bidi-theme-font:major-bidi'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_ecee4c5d-e68e-4b73-8461-9a94585640ea \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>No dose adjustment is needed in patients with solely hepatic impairment.</p><p><strong>Patients with hepatic impairment and renal impairment</strong></p><p>Dose adjustment is recommended <em>(see Renal impairment above)</em>.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cetirizine is contraindicated in:
•	hypersensitivity to any of the constituents of this formulation, to hydroxyzine or to any piperazine derivatives,
•	patients with end-stage renal disease with GFR (Glomerular Filtration Rate) below 15 ml/min.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Alcohol</em></p><p>At therapeutic doses, no clinically significant interactions have been demonstrated with alcohol (for a blood alcohol level of 0.5 g/L).&nbsp; Nevertheless, precaution is recommended if alcohol is taken concomitantly (<em>see Section Interactions</em>).</p><p><em>Increased risk of urinary retention</em></p><p>Caution should be taken in patients with predisposition factors of urinary retention (e.g. spinal cord lesion, prostatic hyperplasia) as cetirizine may increase the risk of urinary retention (see Section Adverse Reactions)</p><p><em>Patients at risk of convulsions</em></p><p>Caution in epileptic patients and patients at risk of convulsions is recommended.</p><p><em>Skin reactions</em></p><p>Pruritus and/or urticaria may occur when cetirizine is stopped, even if those symptoms were not present before treatment initiation (see Section Adverse Reactions). In some cases, the symptoms may be intense and may require treatment to be restarted. The symptoms should resolve when the treatment is restarted.</p><p><em>Children </em></p><p>The use of the film-coated tablet formulation is not recommended in children aged less than 6 years since this formulation does not allow for appropriate dose adaptation. It is recommended to use a paediatric formulation of cetirizine <em>[Please be aware that in some markets, film-coated tablets </em><em>may be indicated in children 12 years and above.]</em></p><p>The use of the hard capsules formulation is not recommended in children aged less than 12 years since this formulation does not allow for appropriate dose adaptation. It is recommended to use a paediatric formulation of cetirizine.</p><p><em>Allergy skin tests</em></p><p>Allergy skin tests are inhibited by antihistamines and a wash-out period of 3 days is recommended before performing them.</p><p><em>Food</em></p><p>The extent of absorption of cetirizine is not reduced with food, although the rate of absorption is decreased.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Due to the pharmacokinetic, pharmacodynamic and tolerance profile of cetirizine, no interactions are expected with this antihistamine. Neither pharmacodynamic nor significant pharmacokinetic interaction was reported in drug-drug interactions studies performed, notably with pseudoephedrine or theophylline (400 mg/day).</p><p><em>Alcohol and other CNS depressants</em></p><p>In sensitive patients, the concurrent use of alcohol or other CNS depressants may cause additional reductions in alertness and impairment of performance, although cetirizine does not potentiate the effect of alcohol (0.5 g/L blood levels) (<em>see Section Warnings and Precautions</em>).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fertility<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_ab49adbd-6261-43d7-9354-b1857cd5af1a \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Limited data is available on human fertility but no safety concern has been identified.</p><p>Animal data show no safety concern for human reproduction.</p><p>Pregnancy<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_b10190a1-3abd-4dd0-9ca9-f650d6688467 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Caution should be exercised when prescribing to pregnant women.</p><p>For cetirizine prospectively collected data on pregnancy outcomes do not suggest potential for maternal or foetal/embryonic toxicity above background rates.</p><p>Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development. <!--[if supportFields]><span
style='mso-bidi-font-size:10.0pt;line-height:150%;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;mso-ansi-language:EN-US;mso-fareast-language:FR-BE;font-weight:normal'><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_ee1edbda-7c46-4448-bdee-9a1743bae3a1 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='mso-bidi-font-size:10.0pt;line-height:150%;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi;mso-ansi-language:EN-US;mso-fareast-language:FR-BE;font-weight:normal'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Lactation<!--[if supportFields]><span lang=EN-GB
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_45cdc0b7-61b0-4fe7-970e-849ff2ee2126 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Cetirizine passes into breast milk. A risk of side effects in breastfed infants cannot be excluded. Caution should be exercised when prescribing cetirizine to lactating women.</p><p>Cetirizine is excreted in human milk at concentrations representing 25% to 90% of those measured in plasma, depending on sampling time after administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Objective measurements of driving ability, sleep latency and assembly line performance have not demonstrated any clinically relevant effects at the recommended dose of 10 mg. However, patients who experience somnolence should refrain from driving, engaging in potentially hazardous activities or operating machinery.</p><p>Patients intending to drive, engaging in potentially hazardous activities or operating machinery should not exceed the recommended dose and should take their response to the medicinal product into account.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Clinical Trial Data<!--[if supportFields]><span lang=EN-GB
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_b89d318f-4222-42f3-93ce-87949c727967 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Clinical studies have shown that cetirizine at the recommended dosage has minor adverse effects on the CNS, including somnolence, fatigue, dizziness and headache.&nbsp;</p><p>In some cases, paradoxical CNS stimulation has been reported.</p><p>Although cetirizine is a selective antagonist of peripheral H<sub>1</sub>-receptors and is relatively free of anticholinergic activity, isolated cases of micturition difficulty, eye accommodation disorders and dry mouth have been reported.</p><p>Instances of abnormal hepatic function with elevated hepatic enzymes accompanied by elevated bilirubin have been reported.&nbsp; Mostly this resolves upon discontinuation of the treatment with cetirizine.</p><p>Double blind controlled clinical trials comparing cetirizine to placebo or other antihistamines at the recommended dosage (10 mg daily for cetirizine), of which quantified safety data are available, included more than 3200 subjects exposed to cetirizine.</p><p>From this pooling, the following adverse reactions were reported for cetirizine 10 mg in the placebo-controlled trials at rates of 1.0 % or greater:</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Adverse reactions</strong></p><p><strong>(WHO-ART)</strong></p></td><td style="vertical-align:top"><p><strong>Cetirizine 10 mg</strong></p><p><strong>(n= 3260)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>(n = 3061)</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>General disorders</em> and administration site conditions<br />Fatigue</p></td><td style="vertical-align:top"><p><br />1.63 %</p></td><td style="vertical-align:top"><p><br />0.95 %</p></td></tr><tr><td style="vertical-align:top"><p><em>Nervous system disorders</em><br />Dizziness<br />Headache</p></td><td style="vertical-align:top"><p><br />1.10 %<br />7.42 %</p></td><td style="vertical-align:top"><p><br />0.98 %<br />8.07 %</p></td></tr><tr><td style="vertical-align:top"><p><em>Gastro-intestinal system disorders</em><br />Abdominal pain<br />Dry mouth<br />Nausea</p></td><td style="vertical-align:top"><p><br />0.98 %<br />2.09 %<br />1.07 %</p></td><td style="vertical-align:top"><p><br />1.08 %<br />0.82 %<br />1.14 %</p></td></tr><tr><td style="vertical-align:top"><p><em>Psychiatric disorders</em><br />Somnolence</p></td><td style="vertical-align:top"><p><br />9.63 %</p></td><td style="vertical-align:top"><p><br />5.00 %</p></td></tr><tr><td style="vertical-align:top"><p><em>Respiratory thoracic and mediastinal disorders</em><br />Pharyngitis</p></td><td style="vertical-align:top"><p><br />1.29 %</p></td><td style="vertical-align:top"><p><br />1.34 %</p></td></tr></tbody></table><p>&nbsp;</p><p>Although statistically more common than under placebo, somnolence was mild to moderate in the majority of cases.&nbsp;</p><p>Objective tests as demonstrated by other studies have demonstrated that usual daily activities are unaffected at the recommended daily dose in healthy young volunteers.</p><p><em>Paediatric population</em></p><p>Adverse reactions at rates of 1 % or greater in children aged from 6&nbsp;months to 12 years, included in placebo-controlled clinical trials are:</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Adverse reactions</strong></p><p><strong>(WHO-ART)</strong></p></td><td style="vertical-align:top"><p><strong>Cetirizine</strong></p><p><strong>(n=1656)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>(n =1294)</strong></p></td></tr><tr><td><p><em>Gastro-intestinal system disorders</em><br />Diarrhoea</p></td><td><p><br />1.0 %</p></td><td><p><br />0.6 %</p></td></tr><tr><td><p><em>Psychiatric disorders</em><br />Somnolence</p></td><td><p><br />1.8 %</p></td><td><p><br />1. 4 %</p></td></tr><tr><td><p><em>Respiratory thoracic and mediastinal disorders</em><br />Rhinitis</p></td><td><p><br />1.4 %</p></td><td><p><br />1.1 %</p></td></tr><tr><td><p><em>General disorders</em> and administration site conditions<br />Fatigue</p></td><td><p><br />1.0 %</p></td><td><p><br />0.3 %</p></td></tr></tbody></table><p>&nbsp;</p><p>Post Marketing Data<!--[if supportFields]><span lang=EN-GB
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_001f0836-cffa-4586-8e83-1d66a9a0550f \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency.</p><p>Frequencies are defined as:</p><p>Very common &ge;1/10</p><p>Common &ge;1/100 to &lt;1/10</p><p>Uncommon &ge;1/1000 to &lt;1/100</p><p>Rare &ge;1/10000 to &lt;1/1000</p><p>Very rare &lt;1/10000</p><p>Not known (cannot be estimated from the available data).</p><p><em>Blood and lymphatic system disorders</em></p><p><em>Very rare</em>: thrombocytopenia</p><p><em>Immune system disorders</em></p><p><em>Rare:</em> hypersensitivity</p><p><em>Very rare</em>: anaphylactic shock</p><p><em>Metabolism and nutrition disorders</em></p><p><em>Not known: </em>increased appetite</p><p><em>Psychiatric disorders</em></p><p><em>Uncommon:</em> agitation</p><p><em>Rare:</em> aggression, confusion, depression, hallucination, insomnia</p><p><em>Very rare</em>: tics</p><p><em>Not known: </em>suicidal ideation, nightmare</p><p><em>Nervous system disorders</em></p><p><em>Uncommon:</em> paraesthesia</p><p><em>Rare:</em> convulsions</p><p><em>Very rare</em>: dysgeusia, dyskinesia, dystonia, syncope, tremor</p><p><em>Not known</em>: amnesia, memory impairment</p><p><em>Eye disorders</em></p><p><em>Very rare</em>: accommodation disorder, blurred vision, &nbsp;oculogyric crisis</p><p><em>Ear and labyrinth disorders</em></p><p><em>Not known: </em>vertigo</p><p><em>Cardiac disorders</em></p><p><em>Rare</em>: tachycardia</p><p><em>Gastrointestinal disorders</em></p><p><em>Uncommon:</em> diarrhoea</p><p><em>Hepatobiliary disorders</em></p><p><em>Rare: </em>hepatic function abnormal (transaminases increased, blood bilirubin increased, blood alkaline phosphatase increased, gamma-glutamyl transferase increased)<br />Not known: hepatitis</p><p><em>Skin and subcutaneous tissue disorders</em></p><p><em>Uncommon</em>: pruritus, rash</p><p><em>Rare:</em> urticaria</p><p><em>Very rare</em>: angioedema, fixed drug eruption<br /><em>Not known: acute generalized exanthematous pustulosis (AGEP)</em></p><p><em>Musculoskeletal and connective tissue disorders</em></p><p><em>Not known: arthralgia</em> <em>, myalgia</em></p><p><em>Renal and urinary disorders</em></p><p><em>Very rare</em>: dysuria, enuresis</p><p><em>Not known:</em> urinary retention <em>(see Section Warnings and Precautions)</em></p><p><em>General disorders and administration site conditions</em></p><p><em>Uncommon:</em> asthenia, malaise</p><p><em>Rare:</em> oedema</p><p><em>Investigations</em></p><p>Rare: weight increased.</p><p><em><u>Skin reactions occuring after discontinuation of cetirizine</u></em></p><p>After discontinuation of cetirizine, pruritus (intense itching) and/or urticaria have been reported <em>(see Section Warnings and Precautions)</em>.</p><p><strong>To report any side effect(s): </strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>National Pharmacovigilance centre (NPC) </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting Hotline: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa &nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa &nbsp;&nbsp;&nbsp;</p><p><strong>-GSK - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: Saudi.safety@gsk.com</li><li>Website: https://gskpro.com/en-sa/</li><li>P.O Box 55850, Jeddah 21544, Saudi Arabia.</li></ul><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK- Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/<u> </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms and signs<!--[if supportFields]><span lang=EN-GB
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_d711ea65-dfa2-4894-ba25-d9c892bb90cf \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Symptoms observed after an overdose of cetirizine are mainly associated with CNS effects or with effects that could suggest an anticholinergic effect.</p><p>Adverse events reported after an intake of at least 5 times the recommended daily dose are: confusion, diarrhoea, dizziness, fatigue, headache, malaise, mydriasis, pruritus, restlessness, sedation, somnolence, stupor, tachycardia, tremor, and urinary retention.</p><p><strong>Treatment<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_8573582f-8ffd-491e-b065-55da40b19053 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>There is no known specific antidote to cetirizine.</p><p>Should overdose occur, symptomatic or supportive treatment is recommended.</p><p>Cetirizine is not effectively removed by haemodialysis.</p><p>Management should be as clinically indicated or as recommended by the national poisons centre, where available.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_d2ebf771-63bd-44c3-a2df-c30d257e423c \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Antihistamines for systemic use, piperazine derivatives</p><p><strong>ATC Code<!--[if supportFields]><span lang=EN-GB
style='font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_54fb3fd3-bfcc-4ccf-ada8-3f2e0c8ce9e7 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>R06AE07</p><p><strong>Mechanism of Action and Pharmacodynamic effects<!--[if supportFields]><span
lang=EN-GB style='font-size:12.0pt;line-height:150%;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_90e4c925-b2f5-4a52-8fcf-298d8331d9ae \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-size:12.0pt;line-height:150%;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi'><span style='mso-element:field-end'></span></span><![endif]--></p><p>Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H<sub>1</sub>-receptors.&nbsp; <em>In vitro </em>receptor binding studies have shown no measurable affinity for receptors other than H<sub>1</sub>-receptors.</p><p>Studies in healthy volunteers show that cetirizine, at doses of 5 and 10 mg strongly inhibits the wheal and flare reactions induced by very high concentrations of histamine into the skin, but the correlation with efficacy is not established. The onset of activity after a single 10 mg dose occurs within 20 minutes in 50 % of the subjects and within one hour in 95%.&nbsp; This activity persists for at least 24 hours after a single administration.&nbsp;</p><p>In a six-week, placebo-controlled study of 186 patients with allergic rhinitis and concomitant mild to moderate asthma, cetirizine 10 mg once daily improved rhinitis symptoms and did not alter pulmonary function. This study supports the safety of administering cetirizine to allergic patients with mild to moderate asthma.</p><p>In a placebo-controlled study, cetirizine given at the high daily dose of 60 mg for seven days did not cause statistically significant prolongation of QT interval.</p><p>At the recommended dosage, cetirizine has demonstrated that it improves the quality of life of patients with perennial and seasonal allergic rhinitis.</p><p>In a 35-day study in children aged 5 to 12, no tolerance to the antihistaminic effect (suppression of wheal and flare) of cetirizine was found.&nbsp; When a treatment with cetirizine is stopped after repeated administration, the skin recovers its normal reactivity to histamine within 3 days.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_ef8f0304-4516-4376-855e-f9a9fb9c7bb3 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>The steady - state peak plasma concentration is approximately 300 ng/ml and is achieved within 1.0 &plusmn; 0.5 h.</p><p>The distribution of pharmacokinetic parameters such as peak plasma concentration (C<sub>max</sub>) and area under curve (AUC), is unimodal.</p><p>The extent of absorption of cetirizine is not reduced with food, although the rate of absorption is decreased.&nbsp; The extent of bioavailability is similar when cetirizine is given as solutions, capsules or tablets.</p><p><strong>Distribution</strong></p><p>The apparent volume of distribution is 0.50 l/kg. Plasma protein binding of cetirizine is 93 &plusmn; 0.3 %. Cetirizine does not modify the protein binding of warfarin.</p><p><strong>Metabolism and Elimination</strong></p><p>Cetirizine does not undergo extensive first pass metabolism. About two-thirds of the dose is excreted unchanged in urine. The terminal half-life is approximately 10 hours and no accumulation is observed for cetirizine following daily doses of 10 mg for 10 days.</p><p>Cetirizine exhibits linear kinetics over the range 5 to 60 mg.</p><p><strong>Special patient populations<!--[if supportFields]><span lang=EN-GB style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
major-bidi;mso-bidi-theme-font:major-bidi'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_4efc1357-7e8d-4de1-b6ae-6dc65e8f14e3 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p><strong>Children<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_4ff2e29f-9860-4550-b42d-a6d6dad5bb12 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>The half-life of cetirizine was about 6 hours in children of 6-12 years and 5 hours in children 2-6 years. In infants and toddlers aged 6 to 24 months, it is reduced to 3.1 hours.</p><p><strong>Elderly<!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_e912c889-db3c-4185-9efb-b68885770118 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Following a single 10 mg oral dose, the half-life increased by about 50 % and clearance decreased by 40 % in 16 elderly subjects compared to the younger subjects.&nbsp; The decrease in cetirizine clearance in these elderly volunteers appeared to be related to their decreased renal function.</p><p><strong>Renal impairment<!--[if supportFields]><span lang=EN-GB style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
major-bidi;mso-bidi-theme-font:major-bidi'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_944d910c-b8a3-4625-982e-81b819a7a27b \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>The pharmacokinetics of the drug was similar in patients with mild impairment (creatinine clearance higher than 40 ml/min) and healthy volunteers.&nbsp;&nbsp; Patients with moderate renal impairment had a 3-fold increase in half-life and 70% decrease in clearance compared to healthy volunteers.</p><p>Patients on haemodialysis (creatinine clearance less than 7 ml/min) given a single oral 10 mg dose of cetirizine had a 3-fold increase in half-life and a 70% decrease in clearance compared to normal.&nbsp; Cetirizine was poorly cleared by haemodialysis.&nbsp; Dosing adjustment is necessary in patients with moderate or severe renal impairment.</p><p><strong>Hepatic impairment<!--[if supportFields]><span lang=EN-GB style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
major-bidi;mso-bidi-theme-font:major-bidi'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_bb68e09f-bc5e-4dae-bd6f-67bff8f8e1ca \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Patients with chronic liver diseases (hepatocellular, cholestatic, and biliary cirrhosis) given 10 or 20 mg of cetirizine as a single dose had a 50% increase in half-life along with a 40% decrease in clearance compared to healthy subjects.</p><p>Dosing adjustment is only necessary in hepatically impaired patients if concomitant renal impairment is present.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant for this product.</p><p><strong>Non-clinical information<!--[if supportFields]><span lang=EN-GB style='font-family:
"Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
major-bidi;mso-bidi-theme-font:major-bidi'><span style='mso-element:field-begin'></span>
DOCVARIABLE VAULT_ND_dc9fb5db-9ae1-48db-9ab7-847f4c562628 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;</strong><!--[if supportFields]><span
lang=EN-GB style='font-family:"Times New Roman",serif;mso-ascii-theme-font:
major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-end'></span></span><![endif]--></p><p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>6.1.</strong><strong>List of Excipients</strong></p><p>Sorbitol solution at 70 % (non crystallizing)</p><p>Glycerol 85%</p><p>Propylene glycol</p><p>Sodium saccharinate</p><p>Methylparahydroxybenzoate</p><p>Propylparahydroxybenzoate</p><p>Banana flavour 54.330/A (Firmenich)</p><p>Sodium Acetate</p><p>Glacial Acetic Acid</p><p>Purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no relevant data available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The expiry date is indicated on the packaging.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg; C in a dry place.</p><p>After-first opening, bottle should be stored at room temperature and to be used within 3 months.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Amber glass bottle (type III Ph. Eur.) closed with a white polypropylene &ldquo;child-proof&rdquo; cap. Bottle of 75 ml.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no special requirements for use or handling of this product</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Trademarks are owned by or licensed to the GSK group of companies
© 2023 GlaxoSmithKline, all rights reserved.

Manufactured by:
Aesica Pharmaceuticals S.R.I., Pianezza, Italy
Marketing Authorization Holder
Glaxo Saudi Arabia Ltd.*, Jeddah, KSA
*member of the GlaxoSmithKline group of companies 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number: 08 
Version date: 11 April 2023 



            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>